WO2010033818A3 - Cibles de miarn - Google Patents
Cibles de miarn Download PDFInfo
- Publication number
- WO2010033818A3 WO2010033818A3 PCT/US2009/057498 US2009057498W WO2010033818A3 WO 2010033818 A3 WO2010033818 A3 WO 2010033818A3 US 2009057498 W US2009057498 W US 2009057498W WO 2010033818 A3 WO2010033818 A3 WO 2010033818A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mirna targets
- targets
- mirna
- isolating
- identifying
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
- C12N2320/11—Applications; Uses in screening processes for the determination of target sites, i.e. of active nucleic acids
Abstract
La présente invention concerne des systèmes pour identifier, isoler et/ou caractériser des cibles de microARN.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/063,156 US20120040851A1 (en) | 2008-09-19 | 2009-09-18 | miRNA TARGETS |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9869608P | 2008-09-19 | 2008-09-19 | |
US9870708P | 2008-09-19 | 2008-09-19 | |
US61/098,696 | 2008-09-19 | ||
US61/098,707 | 2008-09-19 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2010033818A2 WO2010033818A2 (fr) | 2010-03-25 |
WO2010033818A8 WO2010033818A8 (fr) | 2010-05-06 |
WO2010033818A3 true WO2010033818A3 (fr) | 2010-07-01 |
Family
ID=42040163
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/057506 WO2010033822A2 (fr) | 2008-09-19 | 2009-09-18 | Stratégies thérapeutiques et diagnostiques |
PCT/US2009/057498 WO2010033818A2 (fr) | 2008-09-19 | 2009-09-18 | Cibles de miarn |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/057506 WO2010033822A2 (fr) | 2008-09-19 | 2009-09-18 | Stratégies thérapeutiques et diagnostiques |
Country Status (2)
Country | Link |
---|---|
US (3) | US9347089B2 (fr) |
WO (2) | WO2010033822A2 (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120315640A1 (en) * | 2009-12-21 | 2012-12-13 | Hidetoshi Tahara | Senescence marker, method for evaluating senescence inhibitor, and cancer inhibitor |
WO2011138787A1 (fr) * | 2010-05-05 | 2011-11-10 | Ariel - University Research And Development Company, Ltd. | Identification de microarn spécifiques à un arnm |
US9212387B2 (en) | 2010-06-17 | 2015-12-15 | National University Corporation Okayama University | Method for detection of genes targeted by microRNA |
WO2014113668A1 (fr) * | 2013-01-18 | 2014-07-24 | Children's Medical Center Corporation | Cibles de miarn |
US9116866B2 (en) | 2013-08-21 | 2015-08-25 | Seven Bridges Genomics Inc. | Methods and systems for detecting sequence variants |
US9898575B2 (en) | 2013-08-21 | 2018-02-20 | Seven Bridges Genomics Inc. | Methods and systems for aligning sequences |
WO2015058093A1 (fr) | 2013-10-18 | 2015-04-23 | Seven Bridges Genomics Inc. | Procédés et systèmes pour le génotypage d'échantillons génétiques |
US11049587B2 (en) | 2013-10-18 | 2021-06-29 | Seven Bridges Genomics Inc. | Methods and systems for aligning sequences in the presence of repeating elements |
JP2016533182A (ja) | 2013-10-18 | 2016-10-27 | セブン ブリッジズ ジェノミクス インコーポレイテッド | 疾患に誘導された変異を同定するための方法およびシステム |
WO2015058095A1 (fr) | 2013-10-18 | 2015-04-23 | Seven Bridges Genomics Inc. | Procédés et systèmes de quantification d'alignement de séquences |
US9092402B2 (en) | 2013-10-21 | 2015-07-28 | Seven Bridges Genomics Inc. | Systems and methods for using paired-end data in directed acyclic structure |
US9817944B2 (en) | 2014-02-11 | 2017-11-14 | Seven Bridges Genomics Inc. | Systems and methods for analyzing sequence data |
CN107109698B (zh) * | 2014-09-22 | 2021-07-20 | 加利福尼亚大学董事会 | Rna stitch测序:用于直接映射细胞中rna:rna相互作用的测定 |
US9558321B2 (en) | 2014-10-14 | 2017-01-31 | Seven Bridges Genomics Inc. | Systems and methods for smart tools in sequence pipelines |
WO2016141294A1 (fr) | 2015-03-05 | 2016-09-09 | Seven Bridges Genomics Inc. | Systèmes et procédés d'analyse de motifs génomiques |
US20180148792A1 (en) | 2015-05-19 | 2018-05-31 | T.S. Sridhar | Method for Identification of a Deficient BRCA1 Function |
US10275567B2 (en) | 2015-05-22 | 2019-04-30 | Seven Bridges Genomics Inc. | Systems and methods for haplotyping |
US10793895B2 (en) | 2015-08-24 | 2020-10-06 | Seven Bridges Genomics Inc. | Systems and methods for epigenetic analysis |
US10584380B2 (en) | 2015-09-01 | 2020-03-10 | Seven Bridges Genomics Inc. | Systems and methods for mitochondrial analysis |
US10724110B2 (en) | 2015-09-01 | 2020-07-28 | Seven Bridges Genomics Inc. | Systems and methods for analyzing viral nucleic acids |
US11347704B2 (en) | 2015-10-16 | 2022-05-31 | Seven Bridges Genomics Inc. | Biological graph or sequence serialization |
US20170199960A1 (en) | 2016-01-07 | 2017-07-13 | Seven Bridges Genomics Inc. | Systems and methods for adaptive local alignment for graph genomes |
US10364468B2 (en) | 2016-01-13 | 2019-07-30 | Seven Bridges Genomics Inc. | Systems and methods for analyzing circulating tumor DNA |
US10460829B2 (en) | 2016-01-26 | 2019-10-29 | Seven Bridges Genomics Inc. | Systems and methods for encoding genetic variation for a population |
US10262102B2 (en) | 2016-02-24 | 2019-04-16 | Seven Bridges Genomics Inc. | Systems and methods for genotyping with graph reference |
US11250931B2 (en) | 2016-09-01 | 2022-02-15 | Seven Bridges Genomics Inc. | Systems and methods for detecting recombination |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050260648A1 (en) * | 2004-04-06 | 2005-11-24 | Huffel Christophe V | Method for the determination of cellular transcriptional |
US20070072204A1 (en) * | 2005-05-02 | 2007-03-29 | Hannon Gregory J | Compositions and methods for cancer diagnosis and treatment |
US20070087335A1 (en) * | 2005-10-10 | 2007-04-19 | Council Of Scientific And Industrial Research | Human microRNA targets in HIV genome and a method of identification thereof |
US20080166707A1 (en) * | 2004-04-20 | 2008-07-10 | Jian Han | Method for Detecting ncRna |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040175732A1 (en) * | 2002-11-15 | 2004-09-09 | Rana Tariq M. | Identification of micrornas and their targets |
EP2471924A1 (fr) * | 2004-05-28 | 2012-07-04 | Asuragen, INC. | Procédés et compositions impliquant du microARN |
EP2302055B1 (fr) * | 2004-11-12 | 2014-08-27 | Asuragen, Inc. | Procédés et compositions impliquant l'ARNmi et des molécules inhibitrices de l'ARNmi |
US8592384B2 (en) | 2005-04-04 | 2013-11-26 | The Board Of Regents Of The University Of Texas System | Micro-RNA's that regulate muscle cells |
GB2425311A (en) * | 2005-04-15 | 2006-10-25 | Ist Superiore Sanita | Micro RNA against kit protein |
EP2487240B1 (fr) * | 2006-09-19 | 2016-11-16 | Interpace Diagnostics, LLC | Micro ARN différemment exprimés dans des maladies pancréatiques et leurs utilisations |
US20100029501A1 (en) * | 2008-07-09 | 2010-02-04 | Eva Samal | Method of identifying micro-rna targets |
-
2009
- 2009-09-18 US US13/063,155 patent/US9347089B2/en active Active
- 2009-09-18 US US13/063,156 patent/US20120040851A1/en not_active Abandoned
- 2009-09-18 WO PCT/US2009/057506 patent/WO2010033822A2/fr active Application Filing
- 2009-09-18 WO PCT/US2009/057498 patent/WO2010033818A2/fr active Application Filing
-
2016
- 2016-05-23 US US15/162,337 patent/US20160369274A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050260648A1 (en) * | 2004-04-06 | 2005-11-24 | Huffel Christophe V | Method for the determination of cellular transcriptional |
US20080166707A1 (en) * | 2004-04-20 | 2008-07-10 | Jian Han | Method for Detecting ncRna |
US20070072204A1 (en) * | 2005-05-02 | 2007-03-29 | Hannon Gregory J | Compositions and methods for cancer diagnosis and treatment |
US20070087335A1 (en) * | 2005-10-10 | 2007-04-19 | Council Of Scientific And Industrial Research | Human microRNA targets in HIV genome and a method of identification thereof |
Non-Patent Citations (1)
Title |
---|
ANGIE M. CHENG ET AL.: "Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis.", NUCLEIC ACIDS RESEARCH, vol. 33, no. 4, 2005, pages 1290 - 1297 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010033818A8 (fr) | 2010-05-06 |
US20160369274A1 (en) | 2016-12-22 |
US20120040851A1 (en) | 2012-02-16 |
WO2010033822A2 (fr) | 2010-03-25 |
US20120059043A1 (en) | 2012-03-08 |
WO2010033822A3 (fr) | 2010-07-01 |
US9347089B2 (en) | 2016-05-24 |
WO2010033818A2 (fr) | 2010-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010033818A8 (fr) | Cibles de miarn | |
WO2008127784A3 (fr) | Vêtements de protection avec systèmes d'ouverture rapide et procédés associés | |
WO2007148300A3 (fr) | Méthodes et systèmes de stockage de contenus obtenus par la technologie 'pousser' | |
WO2010148275A3 (fr) | Système bioréacteur | |
WO2011028807A3 (fr) | Systèmes et procédés de métrologie | |
WO2009130479A3 (fr) | Virus | |
WO2010062328A3 (fr) | Système de distribution | |
WO2012047618A3 (fr) | Biomarqueurs de mésothéliome et utilisations de ceux-ci | |
WO2011072099A3 (fr) | Compositions et procédés comprenant des variants de protéase | |
WO2008046104A3 (fr) | Procédés et systèmes de découverte de connaissances | |
EP2346553A4 (fr) | Systèmes et procédés d'identification d'un orifice d'accès | |
WO2010048585A3 (fr) | Composés oligomères et méthodes | |
WO2011139311A3 (fr) | Turbine à gaz et système de refroidissement | |
WO2007149621A3 (fr) | Procédés et systèmes pour l'identification et l'authentification d'objets | |
WO2009155502A3 (fr) | Procédés informatiques, support lisible par ordinateur et systèmes pour déterminer une ou plusieurs caractéristiques d'une plaquette | |
WO2010144145A3 (fr) | Revêtements et gaines à gradient de fonctionnalité permettant de protéger contre la corrosion et les fortes températures | |
EP2310945A4 (fr) | Systèmes et procédés pour régler un système d'exploitation, une application, ou un composant réseau | |
WO2008070269A3 (fr) | Procédés, logiciel et systèmes d'imagerie | |
WO2010091308A3 (fr) | Composés oligomères et procédés connexes | |
WO2009130649A3 (fr) | Vésicules de membrane plasmique et procédés pour les préparer et les utiliser | |
WO2008066869A3 (fr) | Systèmes et procédés de suivi de l'amplification et du comportement en matière de dissociation de molécules d'adn | |
WO2011019426A3 (fr) | Systèmes de détection des alentours et procédés correspondants | |
WO2011022099A3 (fr) | Systèmes d'identification flexibles et procédés associés | |
WO2010123901A8 (fr) | Système de lavage du côlon | |
WO2009114724A3 (fr) | COMPOSITIONS COMPRENANT DU SIARN DE FACTEUR NUCLÉAIRE-KAPPA B (NF-ĸB), ET PROCÉDÉS D’UTILISATION DE CEUX-CI |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09815277 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13063156 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09815277 Country of ref document: EP Kind code of ref document: A2 |